
PP92. APOLIPOPROTEIN E AND ALZHEIMER DISEASE IN BULGARIAN PATIENTS I. YORDANOVA1,2, S. Mehrbian3, J. Genova 4, M. Raycheva3, I. Kremensky1,2, L. Traykov3, A. Jordanova 1,2
1. National Genetics Laboratory, Laboratory of Molecular Pathology; 2. Molecular Medicine Center; 3. Department of Neurology; 4. Department of Chemistry and Biochemistry, Medical University - Sofia, Bulgaria
e-mail: igli4eto@yahoo.com
*Corresponding Author: page: 88
|
Abstract
Alzheimer disease (AD) is the most frequent cause of dementia, associated with various genetic and non-genetic factors. Apolipoprotein E (ApoE) is a multifunctional protein with central role in the lipid metabolism and neurobiology. ApoE has three common isoforms (e2, e3, e4), encoded by different alleles of a single gene. Among the genetic factors involved in AD susceptibility, the ApoEe4 allele has a major contribution and its presence reduces the age at AD onset.
We aimed to determine the effect of ApoE genotype on the risk of AD in elderly Bulgarians. We genotyped 53 patients with early-onset (EOAD), 58 - with late-onset (LOAD) and 39 gender-, age- and ethnically matched controls individuals. All patients were diagnosed by two referent clinicians according to NINCDS-ADRDA criteria for probable AD. The ApoE genotyping included standard PCR-RFLP analysis followed by polyacrylamide gel electrophoresis and silver staining visualization.
ApoEe3 was the most common allele in the three groups, with significantly higher frequency among the EOAD (87%), than the LOAD patients (72%, p<0.05). In contrast, ApoEe4 allele was significantly more common among the LOAD patients (25%) than in the control (9%, p<0.005) or EOAD (10%, p<0.01) individuals. This allele was found in homo-or heterozygous state in about 50% of AD patients with onset above 65 years of age. There were no gender differences in the ApoE allele distribution. This is the first ApoE association study in Bulgaria. Our data suggest an association of ApoEe4 allele with increased risk of LOAD, but not EOAD in Bulgarian individuals.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|